The FDA has banned products from a Chinese API maker and suggested it get a consultant to direct upgrades after an inspection found serious problems in its manufacturing processes, some of which had ...
A Japanese API maker told the FDA that it had a “lack of awareness of the seriousness” of its GMP violations after admitting to the agency that it had manipulated data during its API testing. The ...
The world’s number two producer of active pharmaceutical ingredients (APIs) is for sale. Given the constant global demand for essential medicines, the business might seem like a lucrative asset. But ...
Human API, maker of a consumer-facing health data sharing platform, announced last week the close of "over $20 million" in Series C funding. The raise saw backers Samsung Ventures, CNO Financial Group ...
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More On average, it costs $20,000 USD to build an application programming ...
An arm of the private equity firm TPG will invest $30 million in Solara Active Pharma, a maker of active pharmaceutical ingredients (APIs). Solara has five manufacturing sites and two research centers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results